A-54145 B
| Internal ID | 15f066c6-6026-4fb3-b433-a7e00eb67cf2 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (4R)-5-[[(2S,3R)-4-amino-1-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-18-(4-aminobutyl)-9-(2-amino-2-oxoethyl)-3-[(2S)-butan-2-yl]-15-[(R)-carboxy(methoxy)methyl]-21-(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-24,28,31-trimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-3-hydroxy-1,4-dioxobutan-2-yl]amino]-4-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C73H111N17O27/c1-9-11-12-13-14-15-16-24-48(92)80-44(29-39-32-77-41-22-18-17-21-40(39)41)65(106)83-43(25-26-51(95)96)64(105)88-57(59(101)61(76)102)70(111)87-56-38(6)117-73(115)55(35(3)10-2)86-69(110)54(36(4)28-52(97)98)85-67(108)45(30-47(75)91)81-49(93)33-78-68(109)58(60(116-8)72(113)114)89-63(104)42(23-19-20-27-74)82-66(107)46(31-53(99)100)84-62(103)37(5)79-50(94)34-90(7)71(56)112/h17-18,21-22,32,35-38,42-46,54-60,77,101H,9-16,19-20,23-31,33-34,74H2,1-8H3,(H2,75,91)(H2,76,102)(H,78,109)(H,79,94)(H,80,92)(H,81,93)(H,82,107)(H,83,106)(H,84,103)(H,85,108)(H,86,110)(H,87,111)(H,88,105)(H,89,104)(H,95,96)(H,97,98)(H,99,100)(H,113,114)/t35-,36+,37-,38+,42+,43+,44-,45+,46-,54-,55-,56-,57-,58-,59+,60+/m0/s1 |
| InChI Key | IXYMYSZPMWIOEU-KRNKDTLPSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C73H111N17O27 |
| Molecular Weight | 1658.80 g/mol |
| Exact Mass | 1657.78353133 g/mol |
| Topological Polar Surface Area (TPSA) | 702.00 Ų |
| XlogP | -4.70 |
| Atomic LogP (AlogP) | -5.83 |
| H-Bond Acceptor | 24 |
| H-Bond Donor | 21 |
| Rotatable Bonds | 38 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6058 | 60.58% |
| Caco-2 | - | 0.8616 | 86.16% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.4976 | 49.76% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8055 | 80.55% |
| OATP1B3 inhibitior | + | 0.9161 | 91.61% |
| MATE1 inhibitior | - | 0.7609 | 76.09% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9611 | 96.11% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8826 | 88.26% |
| CYP3A4 substrate | + | 0.7594 | 75.94% |
| CYP2C9 substrate | - | 0.7932 | 79.32% |
| CYP2D6 substrate | - | 0.8017 | 80.17% |
| CYP3A4 inhibition | - | 0.8048 | 80.48% |
| CYP2C9 inhibition | - | 0.8365 | 83.65% |
| CYP2C19 inhibition | - | 0.8880 | 88.80% |
| CYP2D6 inhibition | - | 0.8978 | 89.78% |
| CYP1A2 inhibition | - | 0.9191 | 91.91% |
| CYP2C8 inhibition | + | 0.8443 | 84.43% |
| CYP inhibitory promiscuity | - | 0.9291 | 92.91% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8900 | 89.00% |
| Carcinogenicity (trinary) | Non-required | 0.5993 | 59.93% |
| Eye corrosion | - | 0.9882 | 98.82% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7735 | 77.35% |
| Skin corrosion | - | 0.9315 | 93.15% |
| Ames mutagenesis | - | 0.7437 | 74.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7090 | 70.90% |
| Micronuclear | + | 0.8300 | 83.00% |
| Hepatotoxicity | - | 0.6624 | 66.24% |
| skin sensitisation | - | 0.8872 | 88.72% |
| Respiratory toxicity | + | 0.7111 | 71.11% |
| Reproductive toxicity | + | 0.9889 | 98.89% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | + | 0.6707 | 67.07% |
| Acute Oral Toxicity (c) | III | 0.5594 | 55.94% |
| Estrogen receptor binding | - | 0.5450 | 54.50% |
| Androgen receptor binding | + | 0.7266 | 72.66% |
| Thyroid receptor binding | + | 0.8004 | 80.04% |
| Glucocorticoid receptor binding | + | 0.8398 | 83.98% |
| Aromatase binding | + | 0.8205 | 82.05% |
| PPAR gamma | + | 0.7769 | 77.69% |
| Honey bee toxicity | - | 0.6140 | 61.40% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.5000 | 50.00% |
| Fish aquatic toxicity | + | 0.7189 | 71.89% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.91% | 98.95% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.82% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.36% | 96.09% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.28% | 96.61% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 98.75% | 99.17% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 97.76% | 91.81% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 96.94% | 95.56% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.79% | 97.64% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 95.73% | 85.14% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 95.37% | 94.45% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 95.35% | 96.11% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 94.37% | 88.42% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 94.30% | 95.00% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 94.26% | 90.20% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 93.20% | 92.08% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 92.94% | 90.08% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 92.94% | 83.82% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.94% | 97.14% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 92.65% | 97.09% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 92.28% | 93.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 92.19% | 99.23% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 92.01% | 98.05% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 91.65% | 82.38% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.63% | 93.10% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.34% | 96.90% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 90.95% | 89.62% |
| CHEMBL4071 | P08311 | Cathepsin G | 90.74% | 94.64% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 90.13% | 98.33% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 89.79% | 96.28% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 88.98% | 95.56% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 88.95% | 92.32% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.56% | 89.50% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 88.11% | 86.33% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 87.99% | 93.99% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 87.50% | 97.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.08% | 96.47% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.96% | 98.75% |
| CHEMBL1949 | P62937 | Cyclophilin A | 86.46% | 98.57% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 86.44% | 96.25% |
| CHEMBL4801 | P29466 | Caspase-1 | 86.14% | 96.85% |
| CHEMBL3776 | Q14790 | Caspase-8 | 86.14% | 97.06% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 85.81% | 95.50% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 85.60% | 96.00% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 84.52% | 97.23% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 84.00% | 89.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 83.71% | 88.56% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.29% | 95.89% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 82.69% | 95.38% |
| CHEMBL3891 | P07384 | Calpain 1 | 82.26% | 93.04% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 81.82% | 93.18% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 81.56% | 100.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.69% | 94.66% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 80.36% | 95.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101415128 |
| LOTUS | LTS0275370 |
| wikiData | Q105122584 |